SpyGlass Pharma Cash Flow Statement (2025-2026) | SGP

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2025	Jun2026
Operating Activities
Net Income (Quarter)	-8.68M	-19.86M
Depreciation and Depletion (Quarter)	0.14M	0.34M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)	0.14M	0.34M

SpyGlass Pharma (SGP)

NASDAQ: SGP

$26.20 ▲ +1.03 (+4.09%)

Aug 14, 2026 · 4:00 PM UTC